ArticleJournal of the National Comprehensive Cancer Network : JNCCN2019
Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment.
Article in Journal of the National Comprehensive Cancer Network : JNCCN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Effect of Geospatial and Sociodemographic Factors on Live Birth After Fertility-Sparing Treatment for Breast and Gynecologic Cancers.O&G open · 2025Article
- Role of neighborhood context in ovarian cancer survival disparities: current research and future directions.American journal of obstetrics and gynecology · 2023Review
- Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery.Gynecologic oncology reports · 2022Article
- Spatial-Temporal Trends in Ovarian Cancer Outcomes in California.JNCI cancer spectrum · 2022Article
- Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer.Gynecologic oncology reports · 2022Article
- Feasibility of Linking Area Deprivation Index Data to the OMOP Common Data Model.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2022Article
- Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients.Gynecologic oncology · 2022Article
- Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.Cancer · 2021Article
- A qualitative study on the impact of long-distance travel for gynecologic cancer care.Gynecologic oncology reports · 2021Article
- Rural residence is related to shorter survival in epithelial ovarian cancer patients.Gynecologic oncology · 2021Article
- Racial-Ethnic and Socioeconomic Disparities in Guideline-Adherent Treatment for Endometrial Cancer.Obstetrics and gynecology · 2021Article
- Ovarian cancer in California: Guideline adherence, survival, and the impact of geographic location, 1996-2014.Cancer epidemiology · 2020Article
- Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database.Journal of neuro-oncology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
backgroundMore than 14,000 women in the United States die of ovarian cancer (OC) every year. Disparities in survival have been observed by race and socioeconomic status (SES), and vary spatially even after adjusting for treatment received. This study aimed to determine the impact of geographic location on receiving treatment adherent to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for OC, independent of other predictors. PATIENTS AND
methodsWomen diagnosed with all stages of epithelial OC (1996-2014) were identified through the California Cancer Registry. Generalized additive models, smoothing for residential location, were used to calculate adjusted odds ratios (ORs) and 95% CIs for receiving nonadherent care throughout California. We assessed the impact of distance traveled for care, distance to closest high-quality hospital, race/ethnicity, and SES on receipt of quality care, adjusting for demographic and cancer characteristics and stratifying by disease stage.
resultsOf 29,844 patients with OC, 11,419 (38.3%) received guideline-adherent care. ORs for nonadherent care were lower in northern California and higher in Kern and Los Angeles counties. Magnitudes of associations with location varied by stage (OR range, 0.45-2.19). Living farther from a high-quality hospital increased the odds of receiving nonadherent care (OR, 1.18; 95% CI, 1.07-1.29), but travel >32 km to receive care was associated with decreased odds (OR, 0.76; 95% CI, 0.70-0.84). American Indian/other women were more likely to travel greater distances to receive care. Women in the highest SES quintile, those with Medicare insurance, and women of non-Hispanic black race were less likely to travel far. Patients who were Asian/Pacific Islander lived the closest to a high-quality hospital.
conclusionsAmong California women diagnosed with OC, living closer to a high-quality center was associated with receiving adherent care. Non-Hispanic black women were less likely to receive adherent care, and women with lower SES lived farthest from high-quality hospitals. Geographic location in California is an independent predictor of adherence to NCCN Guidelines for OC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.